side effects of meridia drug

valium iv

001) when compared to placebo, meeting the study's primary endpoint.5 million people in the United States and 4. Multaq should not be coadministered with strong CYP 3A inhibitors or medicinal products that prolong the QT interval.S. side effects of meridia drug Multaq is an anti-arrhythmic indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted. side effects of meridia drug pdf About Atrial Fibrillation/Atrial Flutter Atrial fibrillation is the leading cause of hospitalization for arrhythmia in the U. purchase xanax 2mg on line legal

PARIS, July 02, 2009 /PRNewswire-FirstCall/ --Sanofi-aventis announced today that the U. Such patients should not be given dronedarone.us/Multaq/Multaq. side effects of meridia drug Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease. Most common adverse reactions are diarrhea, nausea, vomiting, abdominal pain, asthenia (weakness) and cutaneous rash. side effects of meridia drug D. In contrast, in ATHENA, all patients had a history of AF/AFL, and 71% of patients had no heart failure, 25% were NYHA class I or II, and only 4% were class III. tramadol in drug screens

Atrial fibrillation is a potentially life-threatening condition, with significant burden on patients, health care providers and payers. Hypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics.sanofi-aventis. About sanofi-aventis Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. side effects of meridia drug Atrial flutter, another type of arrhythmia generating in the atrium, occurs less frequently, and may evolve into atrial fibrillation. side effects of meridia drug " The landmark ATHENA trial evaluated the efficacy and safety of Multaq in patients with AF/AFL or a recent history of these conditions (71% of these patients had no heart failure, 29% were in NYHA class I-III with stable heart failure).